đź’¨ Abstract
X4 Pharmaceuticals, Inc. (XFOR) reported Q1 earnings of $282,000 with a profit of 4 cents per share, exceeding analyst expectations. The company also reported revenue of $28.8 million, surpassing forecasts of $9 million. This news was generated by Automated Insights using data from Zacks Investment Research.
Courtesy: wtop.com
Summarized by Einstein Beta 🤖
Suggested
Weekend round of nuclear talks between US and Iran are postponed, Oman says -
What Is the Average Retirement Savings Balance by Age? -
Will Your Credit Card Work Abroad? -
Today in Sports - Lou Gehrig ends his streak of 2,130 consecutive games played -
Sports on TV for Friday, May 2 -
Kentucky changes its athletic department to an LLC, hoping to become more nimble in finding revenue -
Wiener wonderland: hundreds of dachshunds chase record in Hungary -
Today in Sports - Week Ahead, May 2 - May 8 -
Oman’s foreign minister says next nuclear talks scheduled for Saturday between Iran and US have been postponed -
Los 100 primeros dĂas de Donald Trump: Su relaciĂłn con China, AmĂ©rica Latina y Argentina -
Powered by MessengerX.io